Cameroon's long-ruling president, Paul Biya, wins re-election amid claims of irregularities and deadly clashes between security forces and opposition supporters.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
Cameroon's long-ruling president, Paul Biya, wins re-election amid claims of irregularities and deadly clashes between security forces and opposition supporters.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.